Strategies Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55M Sell
3,791
-271
-7% -$277K 0.41% 29
2026
Q1
$3.74M Buy
4,062
+104
+3% +$105K 0.38% 28
2025
Q4
$4.25M Sell
3,958
-317
-7% -$303K 0.43% 27
2025
Q3
$3.26M Buy
4,275
+404
+10% +$301K 0.34% 28
2025
Q2
$3.02M Buy
3,871
+276
+8% +$214K 0.33% 30
2025
Q1
$2.97M Buy
3,595
+1,049
+41% +$873K 0.36% 30
2024
Q4
$2.22M Buy
+2,546
New +$2.11M 0.28% 34

Other funds holding LLY

Strategies Wealth Advisors's LLY Position: Q2 2026 in Review

Strategies Wealth Advisors reduced its Eli Lilly (LLY) stake by 6.7% in Q2 2026, selling an estimated $277K and leaving 3,791 shares worth $4.55M. The position accounts for 0.41% of the portfolio, ranked #29.

Strategies Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Strategies Wealth Advisors held 3,791 shares of Eli Lilly worth $4.55M as of Q2 2026.
  • Strategies Wealth Advisors sold 271 Eli Lilly shares in Q2 2026, an estimated $277K.
  • Eli Lilly made up 0.41% of Strategies Wealth Advisors's portfolio in Q2 2026, its #29 holding.
  • Strategies Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strategies Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.